Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension,Pulmonary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05087290
What this trial is testing

LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)

Who this might be right for
HypertensionCovid19
University of Glasgow 150
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Early research (Phase 1)Study completedNCT03522935
What this trial is testing

Subcutaneous Elafin in Healthy Subjects

Who this might be right for
Pulmonary Arterial Hypertension
Roham T. Zamanian 30
Testing effectiveness (Phase 2)Ended earlyNCT03556020
What this trial is testing

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 35
Not applicableStudy completedNCT04704440
What this trial is testing

Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil

Who this might be right for
Hypertension, Pulmonary
University of Zurich 24
Not applicableWithdrawnNCT02958358
What this trial is testing

FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan

Who this might be right for
Pulmonary Arterial Hypertension
Robert Scott Harris, M.D.
Not applicableNo Longer AvailableNCT00878943
What this trial is testing

Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Large-scale testing (Phase 3)Looking for participantsNCT05473520
What this trial is testing

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

Who this might be right for
TuberculosisAcute Coronary SyndromePulmonary Hypertension (Diagnosis)
National University Hospital, Singapore 150
Not applicableStudy completedNCT02114047
What this trial is testing

Pulmonary Perfusion Heterogeneity in Patients With CTEPH Using Functional PET Imaging

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Massachusetts General Hospital 5
Large-scale testing (Phase 3)Ended earlyNCT00811018
What this trial is testing

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer 1,192
Large-scale testing (Phase 3)WithdrawnNCT03726398
What this trial is testing

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

Who this might be right for
Interstitial Lung DiseaseSclerodermaPulmonary Hypertension
Franz Rischard, DO
Not applicableLooking for participantsNCT06911632
What this trial is testing

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease (ILD)
Tempus AI 900
Not applicableLooking for participantsNCT05329714
What this trial is testing

PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionGlobal Health
University of Giessen 40,000
Not applicableUnknownNCT00544726
What this trial is testing

Rehabilitation for Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Rabin Medical Center 45
Not applicableStudy completedNCT00011648
What this trial is testing

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Who this might be right for
Pulmonary HypertensionSickle Cell AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 986
Testing effectiveness (Phase 2)Ended earlyNCT00377455
What this trial is testing

Placebo Controlled Trial of Bosentan in Scleroderma Patients

Who this might be right for
Systemic SclerodermaPulmonary Hypertension
Georgetown University 5
Not applicableStudy completedNCT01607489
What this trial is testing

Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography

Who this might be right for
Pulmonary Arterial Hypertension
Medical University of Graz 25
Testing effectiveness (Phase 2)UnknownNCT05747508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon 85
Not applicableLooking for participantsNCT04808596
What this trial is testing

Pulmonary Hypertension Biorepository and Registry

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Left Heart Disease+6 more
University of Kansas Medical Center 300
Not applicableStudy completedNCT02825160
What this trial is testing

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
Bayer 282
Next Page